Skip to search formSkip to main contentSkip to account menu

edoxaban tosylate

Known as: Edoxaban Tosilate, N-(5-Chloropyridin-2-yl)-N'-((1S,2R,4S)-4-(N,N- dimethylcarbamoyl)-2-(5-methyl-4,5,6,7- tetrahydro(1,3)thiazolo(5,4-c)pyridine-2- carboxamido)cyclohexyl)oxamide, 4- methylbenzenesulfonate 
The tosylate salt form of edoxaban, an orally active inhibitor of coagulation factor Xa (activated factor X) with anticoagulant activity. Edoxaban is… 
National Institutes of Health

Related topics

Related topics

4 relations

Narrower (2)

DU-176bSavaysa
edoxabanedoxaban 60 MG Oral Tablet [Savaysa]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Akuttherapie und prolongierte Sekundärprävention venöser Thromboembolien
In dieser offenen Nichtunterlegenheitsstudie wurde der orale Faktor-Xa-Inhibitor Edoxaban (1 × 60 mg nach ≥ 5 Tagen NMH) bei… 
2018
2018
Pacemaker-associated thrombosis in ongoing therapy with edoxaban tosylate
Thromboembolism is a known complication of pacemaker implantation. However, published literature describes only a few cases, in… 
2018
2018
Stability indicating RP-HPLC method for quantification of Edoxaban tosylate
Edoxaban tosylate is a member of the novel oral anti-coagulants (NOACs) class of drugs, and is a rapidly acting, oral, selective… 
2017
2017
Safety of Uninterrupted Periprocedural Edoxaban Versus Phenprocoumon for Patients Who Underwent Left Atrial Catheter Ablation Procedures.
2017
2017
Edoxaban - další z nových perorálních antikoagulancií
Blokatory koagulacniho faktoru Xa se v poslednich letech dostaly do zakladni klinicke praxe a v mnoha indikacich nahrazuji… 
2015
2015
Pharmacokinetics and Pharmacodynamics of the Nonvitamin K Antagonist Oral Anticoagulant Edoxaban When Administered Alone or After Switching from Rivaroxaban or Dabigatran Etexilate in Healthy…
Background and ObjectivesEdoxaban is an oral, once-daily direct factor Xa inhibitor. To support the possibility that patients may… 
Review
2015
Review
2015
Edoxaban tosylate monohydrate, secukinumab, and suvorexant.
Anticoagulant After a period of many decades during which warfarin (Coumadin— Bristol-Myers Squibb) was the standard of treatment… 
2014
2014
Edoxaban was noninferior to warfarin for preventing stroke or systemic embolism in atrial fibrillation
Question In patients with atrial fibrillation (AF) who are at moderate-to-high risk for stroke, is edoxaban noninferior to… 
Review
2011
Review
2011
Edoxaban Tosylate
Daiichi Sankyo is developing edoxaban tosylate (DU 176b; DU-176; DU-176b; DU176b) as an orally active direct factor Xa inhibitor… 
2010
2010
New anticoagulants and the future of cardiology.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)